No association between cytokine gene polymorphism and risk of Alzheimer´s disease in Slovaks

• Autorzy: Shawkatova I. , Javor J. , Parnicka Z. , Vrazda L. , Novak M. , Buc M.
• Języki publikacji: EN

Abstrakty

EN

Clinical and immunopathological evidence support a potential role of inflammatory cytokines in Alzheimer‘s disease (AD). However, studies examining the association between cytokine gene polymorphisms and risk of developing AD yielded conflicting results. The objective of our study was to evaluate the association between the functional polymorphisms in the TNF-α, TGF-β1, IL-10, IL-6 and IFNγ genes, respectively and the risk of AD in Slovak individuals. Fifty sporadic AD patients and 140 non-demented age-matched control subjects were genotyped in our case-control study. The observed allele and genotype frequencies in AD patients and controls did not reveal any statistically significant differences. In conclusion, our data suggest that there is no involvement of cytokine gene genetic variance in the development of AD in the Slovak population.

• Wydawca: -
• Czasopismo: Acta Neurobiologiae Experimentalis
• Rocznik: 2010
• Tom: 70
• Numer: 3
• Opis fizyczny: p.303-307,ref.

Twórcy

autor

Shawkatova I.

• Faculty of Medicine, Institute of Immunology, Comenius University, Bratislava, Slovakia

autor

Javor J.

• Faculty of Medicine, Institute of Immunology, Comenius University, Bratislava, Slovakia

autor

Parnicka Z.

• Faculty of Medicine, Institute of Immunology, Comenius University, Bratislava, Slovakia

autor

Vrazda L.

• Centrum Memory, Bratislava, Slovakia

autor

Novak M.

• Institute of Neuroimmunology, Slovak Academy of Sciences, Bratislava, Slovakia

autor

Buc M.

• Faculty of Medicine, Institute of Immunology, Comenius University, Bratislava, Slovakia

Bibliografia

• Avramopoulos D (2009) Genetics of Alzheimer's disease: recent advances. Genome Med 1: 34.
• Bergem ALM, Engedal K, Kringlen E (1997) The role of heredity in late-onset Alzheimer disease and vascular dementia: a twin study. Arch Gen Psychiatry 54: 264-270.
• Bertram L, Tanzi RE (2004) Alzheimer's disease: one disor­der, too many genes? Hum Mol Genetics 13: 135-141.
• Bertram L, McQueen MB, Mullin K, Blacker D, Tanzi RE (2007) Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat Genet 39 : 17-23.
• Bertram L, Lange C, Mullin K, Parkinson M, Hsiao M, Hogan MF, Schjeide BM, Hooli B, Divito J, Ionita I, Jiang H, Laird N, Moscarillo T, Ohlsen KL, Elliott K, Wang X, Hu-Lince D, Ryder M, Murphy A, Wagner SL, Blacker D, Becker KD, Tanzi RE (2008) Genome-wide association analysis reveals putative Alzheimer's disease susceptibility loci in addition to APOE. Am J Hum Genet 83: 623-32.
• Bertram L, Tanzi RE (2008) Thirty years of Alzheimer's disease genetics: the implication of systematic meta- analyses. Nat Rev Neurosci 9: 768-778.
• Bertram L (2009) Alzheimer's disease genetics current status and future perspectives. Int Rev Neurobiol 84:167-84.
• Bickeboller H, Campion D, Brice A, Amouyel P, Hannequin D, Didierjean O, Penet C, Martin C, Perez-Tur J, Michon A (1997) Apolipoprotein E and Alzheimer disease: Genotype-specific risks by age and sex. Am J Hum Genet 60: 439-446.
• Blacker D, Albert MS, Bassett SS, Go RC, Harrell LE, Folstein MF (1994) Reliability and validity of NINCDS- ADRDA criteria for Alzheimer's disease. The National Institute of Mental Health Genetics Initiative. Arch Neurol 51: 1198-204.
• Blacker D, Bertram L, Saunders AJ, Moscarillo TJ, Albert MS, Wiener H, Perry RT, Collins JS, Harrell LE, Go RCP, Mahoney A, Beaty T, Fallin MD, Avramopoulos D, Chase GA, Folstein MF, McInnis MG, Bassett SS, Doheny KJ, Pugh EW, Tanzi RE (2003) Results of a high-resolution genome screen of 437 Alzheimer's disease families. Hum Mol Genet 12: 23-32.
• Chartier-Harlin MC, Crawford F, Houlden H, Warren A, Hughes D, Fidani L, Goate A, Rossor M, Roques P, Hardy J (1991) Early-onset Alzheimer's disease caused by mutations at codon 717 of the beta-amyloid precursor protein gene. Nature 353: 844-846.
• Daw EW, Payami H, Nemens EJ, Nochlin D, Bird TD, Schellenberg GD, Wijsman EM (2000) The number of trait loci in late-onset Alzheimer disease. Am J Hum Genet 66: 196-204.
• Levy-Lahad E, Wijsman EM, Nemens E, Anderson L, Goddard AB, Weber JL, Bird TD, Schellenberg GD (1995) A familial Alzheimer's disease locus on chromo­some 1. Science 269: 970-973.
• McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34: 939-44.
• Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucl Acids Res 16: 1215.
• Murrell J, Farlow M, Ghetti B and Benson MD (1991) A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease. Science 254: 97-99.
• Rocchi A, Pellegrini S, Siciliano G, Murri L (2003) Causative and susceptibility genes for Alzheimer's disease: A review. Brain Res Bull 61:1-24.
• Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, RosesAD (1993)Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 90: 1977-1981.
• Stozicka Z, Zilka N, Novak M (2007) Risk and protective factors for sporadic Alzheimer's disease. Acta Virologica 51: 205-222.
• Tanzi RE (1999) A genetic dichotomy model for the inheri­tance of Alzheimer's disease and common age-related disorders. J Clin Invest 104: 1175-1179.
• Zekanowski C, Wojda U (2009) Aneuploidy, chromosomal missegregation, and cell cycle reentry in Alzheimer's disease. Acta Neurobiol Exp (Wars) 69:232-253.

Uwagi

PL

Rekord w opracowaniu